{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:46:59Z","timestamp":1772160419309,"version":"3.50.1"},"reference-count":8,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,11,1]]},"DOI":"10.1248\/bpb.b19-00343","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T18:34:00Z","timestamp":1572546840000},"page":"1823-1829","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Measures against Exposure during Administration of Hazardous Drugs through a Feeding Tube"],"prefix":"10.1248","volume":"42","author":[{"given":"Manahito","family":"Aoki","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University"},{"name":"Department of Pharmacy, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Hamasaki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Naya","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shishikura","sequence":"additional","affiliation":[{"name":"Department of Nursing, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University"},{"name":"Department of Pharmacy, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiko","family":"Aoyagi","sequence":"additional","affiliation":[{"name":"Department of Nursing, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Otori","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University"},{"name":"Department of Pharmacy, Kitasato University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) U.S. Department of Health and Human. \u201cNIOSH Alert; preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings in 2004.\u201d: \u2039http:\/\/www.cdc.gov\/niosh\/docs\/2004-165\/pdfs\/2004-165.pdf\u203a, accessed 30 January, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Falck K, Gr\u00f6hn P, Sorsa M, Vainio H, Heinonen E, Holsti LR. Mutagenicity in urine of nurses handling cytostatic drugs. <i>Lancet<\/i>, <b>313<\/b>, 1250\u20131251 (1979).","DOI":"10.1016\/S0140-6736(79)91939-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. <i>J. Occup. Environ. Med.<\/i>, <b>52<\/b>, 1028\u20131034 (2010).","DOI":"10.1097\/JOM.0b013e3181f73ae6"},{"key":"4","unstructured":"4) USP&lt;800&gt; Hazardous drugs\u2014handling in healthcare settings. <i>The United States Pharmacopeia<\/i>, United States Pharmacopeial Convention (2016)."},{"key":"5","unstructured":"5) <i>JSCN\/JSMO\/JASPO Joint Guidelines for Safe Handling of Cancer Chemotherapy Drugs<\/i>. Kanehara Co., Ltd., Tokyo, pp. 1\u201399 (2015)."},{"key":"6","unstructured":"6) Kurata N. <i>Simple suspension method\u2014handbook for tube administration of oral medicines<\/i>. (Fujishima I ed.) Jiho, Inc., Tokyo, pp. 1\u201354 (2015)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Kimu Y, Sakamaki T, Yuasa N, Yoshimasu T, Miyajima A, Hirota T, Komoda M. Influence of using transnasal tubes on the dose of STROMECTOL<sup>\u00ae<\/sup> Tablets. <i>Jpn. J. Pharm. Health Care Sci.<\/i>, <b>40<\/b>, 515\u2013521 (2014).","DOI":"10.5649\/jjphcs.40.515"},{"key":"8","unstructured":"8) Kurata N, Akiyama S, Arai K, Kondo Y, Fujiwara K, Miyagawa T, Ohwaki T, Shinohara K, Nishizono K. Final report by the 6th Subcommittee, Committee on Academics, Japanese Society of Hospital Pharmacists. <i>J. Jpn. Soc. Hosp. Pharm.<\/i>, <b>51<\/b>, 1157\u20131172 (2015)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00343\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T23:21:52Z","timestamp":1572650512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/11\/42_b19-00343\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00343","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]}}}